Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Equillium, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −3 vs. Q1 2024
- Shares held
- 8.89M
- −2.50K (0.0%) vs. Q1 2024
- Total value
- $6.15M
- −$14.4M (−70.0%) vs. Q1 2024
- New holders
- 5
- 6 more added
- Sold out
- 8
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 29 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 43 | $30 | 0.00% | −50,000−99.9% | Reduced |
| Bank of America Corp | 158 | $109 | 0.00% | +158 | New |
| Wells Fargo & Company | 1,000 | $693 | 0.00% | −151−13.1% | Reduced |
| UBS Group AG | 6,287 | $4.36K | 0.00% | +6,287 | New |
| Simplex Trading, LLC | 9,071 | $6.00K | 0.00% | +3,916+76.0% | Added |
| Stifel Financial Corp | 10,119 | $7.01K | 0.00% | 00.0% | Unchanged |
| Tritonpoint Wealth, LLC | 13,500 | $9.36K | 0.00% | +13,500 | New |
| Commonwealth Equity Services, LLC | 25,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 30,506 | $21.0K | 0.00% | +30,506 | New |
| DCF Advisers, LLC | 32,962 | $22.8K | 0.01% | +32,962 | New |
| Northern Trust Corp | 35,019 | $24.3K | 0.00% | −30−0.1% | Reduced |
| BlackRock Inc. | 38,317 | $26.6K | 0.00% | +34,506+905.4% | Added |
| Integrated Wealth Concepts LLC | 40,000 | $27.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 43,504 | $30.2K | 0.00% | +28,850+196.9% | Added |
| State Street Corp | 59,720 | $41.4K | 0.00% | +7,100+13.5% | Added |
| Callan Capital, LLC | 99,688 | $69.1K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 108,691 | $73.0K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 140,775 | $97.6K | 0.02% | −58,000−29.2% | Reduced |
| Geode Capital Management, LLC | 216,204 | $149.9K | 0.00% | +16,476+8.2% | Added |
| Renaissance Technologies LLC | 300,400 | $208.2K | 0.00% | +91,200+43.6% | Added |
| Cota Capital Management, LLC | 562,278 | $389.8K | 1.38% | 00.0% | Unchanged |
| Vanguard Group Inc | 841,948 | $583.6K | 0.00% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 1,824,977 | $1.26M | 0.54% | 00.0% | Unchanged |
| Decheng Capital LLC | 4,447,308 | $3.08M | 0.94% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −41,756−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −40,332−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −31,200−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,897−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −11,433−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −7,359−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −306−100.0% | Sold out |